CLEVELAND BIOLABS INC's ticker is CBLI and the CUSIP is 185860202. A total of 19 filers reported holding CLEVELAND BIOLABS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $17,000 | +13.3% | 4,812 | -35.0% | 0.00% | – |
| Q3 2020 | $15,000 | +1400.0% | 7,398 | +509.9% | 0.00% | – |
| Q3 2019 | $1,000 | -83.3% | 1,213 | -79.7% | 0.00% | – |
| Q4 2018 | $6,000 | +50.0% | 5,981 | +190.9% | 0.00% | – |
| Q3 2018 | $4,000 | +33.3% | 2,056 | +50.1% | 0.00% | – |
| Q2 2018 | $3,000 | -75.0% | 1,370 | -65.1% | 0.00% | – |
| Q1 2018 | $12,000 | +1100.0% | 3,930 | +979.7% | 0.00% | – |
| Q3 2017 | $1,000 | – | 364 | +264.0% | 0.00% | – |
| Q2 2017 | $0 | – | 100 | 0.0% | 0.00% | – |
| Q1 2017 | $0 | -100.0% | 100 | -95.4% | 0.00% | – |
| Q4 2016 | $3,000 | +50.0% | 2,186 | +82.9% | 0.00% | – |
| Q3 2016 | $2,000 | – | 1,195 | +1095.0% | 0.00% | – |
| Q2 2016 | $0 | -100.0% | 100 | -93.2% | 0.00% | – |
| Q1 2016 | $3,000 | -40.0% | 1,479 | +3.9% | 0.00% | – |
| Q4 2015 | $5,000 | – | 1,423 | +681.9% | 0.00% | – |
| Q3 2015 | $0 | -100.0% | 182 | -97.1% | 0.00% | – |
| Q2 2015 | $27,000 | +1250.0% | 6,306 | +1036.2% | 0.00% | – |
| Q1 2015 | $2,000 | – | 555 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 320,053 | $1,104,000 | 0.04% |
| Renaissance Technologies | 165,651 | $571,000 | 0.00% |
| VANGUARD GROUP INC | 52,592 | $181,000 | 0.00% |
| UBS Group AG | 4,812 | $17,000 | 0.00% |
| IFP Advisors, Inc | 150 | $1,000 | 0.00% |
| OSAIC HOLDINGS, INC. | 290 | $1,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 100 | $0 | 0.00% |
| PNC FINANCIAL SERVICES GROUP, INC. | 15,000 | $52,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 34 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |